Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
British Journal of Haematology|December 31, 1997
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodiumC Pouplard, J Amiral, J Y Borg, et al.Pathology|January 1, 1991
Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometryS O Brennan, J Y Borg, G J Shaw, et al.The Thoracic and Cardiovascular Surgeon|April 1, 1982
Follow-up of surgically treated patients with massive pulmonary embolism--with reference to 12 operated patientsR Soyer, A P Brunet, M Redonnet, et al.The Journal of Clinical Investigation|December 1, 1994
Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)D Bruce, D J Perry, J Y Borg, et al.Journal of Neurology|August 5, 2008
The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosisV Le Cam-Duchez, A Bagan-Triquenot, V Barbay, et al.The Journal of Clinical Investigation|April 1, 1988
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to SerJ Y Borg, M C Owen, C Soria, et al.Journal Des Maladies Vasculaires|January 1, 1992
[Acute thrombosis of the right renal vein. Two cases with coagulopathies]H Levesque, J Testart, C Peillon, et al.Blood|May 1, 1987
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to HisM C Owen, J Y Borg, C Soria, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 3, 1999
Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A)E Verspyck, V Le Cam-Duchez, A Gravier, et al.Thrombosis and Haemostasis|March 1, 1996
Five novel mutations of the protein S active gene (PROS 1) in 8 Norman familiesJ Duchemin, J Y Borg, D Borgel, et al.Pageof 6